Pre-clinical development of the BCNAs: The most potent anti-VZV agents reported to date

Christopher McGuigan; Ranjith Pathirana; Marco Migliore; Rina Adak; Annette Angell; G Henson; Robert Snoeck; Graciela Andreï; De Clercq Erik; Jan Balzarini

Related publications

Article2003

Halophenyl Furanopyrimidines as Potent and Selective Anti-VZV Agents

Christopher McGuigan, A Jukes, Sally Blewett, Hubert Barucki, Jonathan T. Erichsen, Graciela Andreï, Robert Snoeck, De Clercq Erik, Jan Balzarini

Article2005

Phosphoramidate prodrugs of the most potent and selective anti-VZV bicyclic pyrimidine nucleosides

M. J. Migliore, Christopher McGuigan, Robert Snoeck, Graciela Andreï, Jan Balzarini, De Clercq Erik

Article2004

Differing SARs and MOAs emerge for the highly potent anti-VZV, BCNAs, and their anti-HCMV dd analogues

Christopher McGuigan, O Bidet, Antonella Carangio, G Luoni, Graciela Andreï, Robert Snoeck, De Clercq Erik, Jan Balzarini

Article2001

Furano Pyrimidines as Novel Potent and Selective Anti-VZV Agents

Christopher McGuigan, Andrea Brancale, Hubert Barucki, S. Srinivasan, G. Jones, Ranjith Pathirana, Antonella Carangio, Sally Blewett, G Luoni, O Bidet, A Jukes, Chris A. Jarvis, Graciela Andreï, Robert Snoeck, De Clercq Erik, Jan Balzarini

Article2006

SAR of alkyloxyphenyl furano pyrimidines: Potent and selective anti-VZV agents

Rina Adak, B Mollwitz, Marco Migliore, Christopher McGuigan, Robert Snoeck, Graciela Andreï, De Clercq Erik, Jan Balzarini